Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Director Declaration

01 June 2018 11:00 BST Director Declaration AstraZeneca PLC (the Company) today announced that Sheri McCoy, a Non-Executive Director of the Company, was appointed as a director of NovoCure Limited following the conclusion of its Annual General Meeting of Shareholders with effect from 31 May 2018. This announcement is made pursuant to Listing Rule 9.6.14 R (2). About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in

Etteplan Oyj - Managers' Transactions

ETTEPLAN OYJ, Stock Exchange Release, June 1, 2018 at 1.00 p.m. Etteplan Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Noksuset OyPosition: Closely associated person(X) Legal person(1):Person Discharging Managerial Responsibilities In IssuerName: Kari LiuskaPosition: Other senior managerIssuer: Etteplan OyjLEI: 743700615533R06JU690Notification type: INITIAL NOTIFICATIONReference number: 743700615533R06JU690_20180601115147_2____________________________________________Transaction date:

Restamax Plc: CORPORATE ACQUISITION OF ROYAL RAVINTOLAT LTD AND SPECIAL SHARE ISSUE REALISED

Restamax PlcSTOCK EXCHANGE RELEASE 1 JUNE 2018 at 13:00CORPORATE ACQUISITION OF ROYAL RAVINTOLAT LTD AND SPECIAL SHARE ISSUE REALISEDOn 12 April 2018, Restamax Plc ("Restamax") announced that it had signed an agreement on the acquisition of the entire share capital of RR Holding Oy ("Royal Ravintolat"). The final implementation of the deal was conditional on a share issue decision by Restamax's General Meeting and on the organising of financing for the cash purchase price.Today, the conditions for carrying out the corporate acquisition were met, and the entire shareholding of Royal

More from the Company Monthly Newsletter May 2018

Dear shareholder, The month of May was marked by the annual general meeting, interim report, participation at the Strokesyd Conference, telephone conferences with potential distributors and saying “farewell” to some of our consultants.We started the month with the annual general meeting and the publication of our interim report. It was nice to meet some of our shareholders who participated at the AGM. We participated at StrokeSyd’s conference and annual meeting in Lund, where both Swedish and foreign researchers and doctors presented and discussed various topics such as risk factors,

AcadeMedia’s subsidiary Hermods has reached a settlement with the City of Malmö regarding the SFI-contract

On March 19, AcadeMedia announced that Hermods had identified a deficiency in their reporting of teacher qualifications to the City of Malmö. Following a dialogue with the City of Malmö a joint agreement has now been reached. On March 19 and 21st  2018 AcadeMedia informed that an internal review had found that the reported information to the City of Malmö on the teacher certification levels was faulty and that this could have a financial effect for Hermods. AcadeMedia immediately informed the City of Malmö about the situation and has since then undertaken several measures to investigate

Groundbreaking pan-cancer screening study published

Solna, Sweden – May 29, 2018 –Baseline data from iCellate’s groundbreaking screening study – Screening Circulating Tumor Cells as a Noninvasive Cancer Test in 3388 Individuals from High-Risk Groups (ICELLATE2) – has been published in the May issue of the journal Disease Markers. iCellate, in collaboration with Hospital Nacional Arzobispo Loayza in Lima, has conducted an all-comers, single center study in a high-risk population (smokers, cancer heredity, hepatitis B or positive PSA) of 3388 subjectively healthy individuals to investigate if screening for CTC (circulating tumor cells) in

EQT Credit provides financing to support the acquisition of Biovian

EQT Credit, through its Mid-Market investment strategy, is pleased to announce that it has provided the financing to support Keensight Capital and ERES’ (the “Shareholders”) investment in Biovian (or the “Company”), a leading European player in contract manufacturing and development of biopharmaceuticals. The Company offers outsourcing services in process development and contract manufacturing for small and medium size biotechnology firms and has deep industry expertise across different key biological processes. Founded in 2003 and based in Turku, Finland, Biovian has 70 employees and a

ÅF establishes a MTN programme

ÅF establishes a domestic Medium Term Note programme with a framework amount of SEK 3 billion. The MTN programme allows ÅF to issue bonds on the Swedish market, and provides a complement to the existing funding structure. The prospectus is available on ÅF’s website www.afconsult.com and will be available at www.finansinspektionen.se. Handelsbanken has been appointed as arranger of the MTN programme and will act as dealer under the programme together with Skandinaviska Enskilda Banken. Corporate CommunicationÅF AB (publ)

Alma Talent to sell its CRM business operations to CRM-service Oy

Alma Media Corporation   Press release   1 June 2018 at 12:00 noon (EET) ALMA TALENT TO SELL ITS CRM BUSINESS OPERATIONS TO CRM-SERVICE OY  Alma Talent Oy, a part of Alma Media, and CRM-service Oy have agreed upon a business transaction where Alma Talent sells its CRM system’s reselling and maintenance business operations to CRM-service. The revenue of the business operations to be transferred in the business transaction was approximately EUR 1.0 million in 2017. The parties have agreed not to publish the price of the transaction. The transaction has no impact on the result of Alma

ZINZINO AB (PUBL.) APPOINTED “GROWTH COMPANY OF THE YEAR 2017” BY DIRECT SELLING SWEDEN

From the left: Jan-Fredrik Torgersen, Chairman of Norwegian DSA , Lars Dahlberg, CMO Zinzino AB and Krister Fraser, Chairman of Direct Selling Sweden. The Direct Sales company Zinzino AB (publ.) received the prestigious award “Growth Company of the Year 2017” from the Direct Selling Association, Direct Selling Sweden. A very happy and proud Lars Dahlberg, CMO at Zinzino AB, received the award for the second time in a row. “To win this award once is very special, but to win it two years in a row is an extraordinary achievement. All credit goes to our hardworking partners in

Kamux Oyj: KAMUX OYJ - Managers' Transactions

KAMUX CORPORATION MANAGERS' TRANSACTIONS 1 June 2018 12:00 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Callardo Capital Oy Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Kalliokoski Juha Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20180601105328_2 _________________________________

Intervacc AB - Nomination Committee’s proposal for Board of Directors for the 2018 Annual General Meeting.

The Nomination Committee hereby announces its proposal regarding the Chairman of the Board of Directors and other Board members to the Annual General Meeting of Intervacc AB (publ) on June 14th, 2018 The Nomination Committee proposes: · that the Board of Directors shall consist of seven members · re-election of the Board members Björn Sjöstrand, Bengt Guss and Stefan Ståhl · Newton Aguiar, Marianne Hansson, Torben Jørgensen and Bert Urlings as new members of the Board of Directors. · that Björn Sjöstrand is elected as Chairman of the Board of Directors since Rune Bergman

Vestas receives 306 MW order from EnerAB derived from a corporate PPA and surpasses 2.1 GW of total order intake in Mexico

News release from Vestas MediterraneanMadrid, 01 June 2018 Vestas receives 306 MW order from EnerAB derived from a corporate PPA and surpasses 2.1 GW of total order intake in Mexico EnerAB, a joint venture between The AES Corporation and Grupo BAL, has placed a 306 MW order with Vestas for the Mesa la Paz wind park that derives from a corporate power purchase agreement (PPA). In recent years, Vestas has increased its manufacturing footprint and commercial offering in Mexico to provide full value chain solutions, which has resulted in orders across different project types, including

Vestas receives 100 MW order in the U.S. for project co-developed with RES America Developments

News release from Vestas-American Wind TechnologyPortland, 01 June 2018 Vestas receives 100 MW order in the U.S. for project co-developed with RES America Developments As Vestas continues to expand strategic initiatives to reflect the evolving energy market, the company is leveraging its unparalleled experience in wind energy solutions to support customers across the entire wind power plant value chain, including co-developing projects together with strategic partners and key customers. By doing so, Vestas aims to engage earlier with customers and build project pipeline whilst

Nordstjernan controls 66.4 per cent of the shares and 72.0 per cent of the votes in Swedol after the expiration of the extended acceptance period

The offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, and no acceptance forms will be accepted from or on behalf of shareholders in, Australia, Hong Kong, Japan, Canada, New Zeeland, South Africa or the USA, or any other jurisdiction where making the offer, the distribution of this press release or acceptance of the offer would be in conflict with any applicable law or regulation or would require any additional offer document or registration or other measures in addition to those required under Swedish law.On March 14, 2018,

Nokian Tyres joins the Science Based Targets initiative and commits to setting climate targets based on current research

Nokian Tyres plc Press Release 1 June 2018 at 11:30 a.m. As a pioneering company, Nokian Tyres wants to contribute to tackling climate change and now the company wants to set ambitious science-based climate targets. This May, Nokian Tyres joined the Science Based Targets initiative with the aim of setting more precise targets that are assessed and approved by an external organisation. Nokian Tyres reached its previously set targets to reduce CO2 emissions  well ahead of

Net Gaming disclosure notice

Net Gaming has received notification of a request for conversion into 1,666,666 new shares, corresponding to SEK 7,499,997 in loans. After the conversion, Trottholmen AB’s holding in Net Gaming will be reduced from 66.74% to 65.21% as a result of dilution. However, there is no change to the number of shares held by Trottholmen, which is still 47,272,382.After implementation of the conversion, the total number of shares will be 72,493,389 after registration with the Swedish Companies Registration Office. This means that Trottholmen AB, currently the Company’s largest shareholder, will see

Request for conversion into shares

Net Gaming has received notifications of requests for conversion into 1,666,666 new shares, corresponding to SEK 7,499,997 in loans.Total number of outstanding shares in the company will now total 72,493,389 once the conversion has been implemented and registered with the Swedish Companies Registration Office. Share capital will now increase by SEK 433,333.16 from SEK 18,414,947.98 to SEK 18,848,281.14. Total outstanding convertible loan now amounts to SEK 14,000,024.50, corresponding to a maximum of 3,111,116 new shares in eventual future conversions into shares. For further

MyFC to showcase integrated prototype of range extender LAMINA REX at Almedalen political week

Over the past year, myFC has worked on the development of a fuel cell-based range extender for electric cars. A commercial electric vehicle is used to develop a prototype to verify myFC’s fuel cell technology. The car will be displayed during the Almedalen political week in July.MyFC initiated the development project toward the automotive industry in order to address the limited range of today's battery technology. The long-term ambition is to solve the limitations in battery performance by integrating the company's fuel cell technology and enabling onboard hydrogen generation, OHG, in

Wilson Therapeutics to present data from WTX101 Phase 2 extension study at 4th Congress of the European Academy of Neurology

Wilson Therapeutics AB (publ) announces that it will present preliminary data from the ongoing extension of the company’s Phase 2 trial of WTX101 (bis-choline tetrathiomolybdate), an investigational first-in-class copper-protein-binding agent under investigation as a novel therapy for Wilson Disease, at the 4th Congress of the European Academy of Neurology (EAN), in Lisbon, Portugal, June 16 – 19, 2018. As previously reported and highlighted in the EAN abstract which is available online today, data from the study support that the initial improvements in free copper levels and hepatic

Kojamo plc: Kojamo announces the preliminary price range for its planned initial public offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Stock Exchange Release June 1, 2018, at 10:30 a.m. EET Kojamo plc ("Kojamo" or the "Company") announces the preliminary price range for the share issue and the share sale in connection with its planned initial public offering (the "Offering"). The Company announced on

PowerCell has received a strategically important order from a global automotive OEM

PowerCell Sweden AB (publ) has received a strategically important order from a global automotive OEM for PowerCell S3 fuel cell stacks and MS-100 fuel cell system for testing and evaluation. The order value amounts to more than MSEK 3.This order represents a natural extension of PowerCell’s cooperation with leading OEMs for the development and production of fuel cell technology for automotive applications. “We are delighted to receive this important order from this particular OEM. The order is a testament to the strength of PowerCell's fuel cell technology for automotive application and

ÅF acquires Facilia – a specialist in nuclear waste management and decommissioning

The acquisition of Facilia strengthens ÅF’s offering within safety assessment for nuclear waste management and decommissioning. With the acquisition ÅF is well positioned for further growth and to support the shifting energy market.Facilia is active in the fields of environmental and health risk assessments, safety assessments in radioactive waste management and radiation protection. The acquisition will strengthen and broaden ÅF’s offer of services and products in the nuclear waste management and decommissioning segments. A combination of ÅF and Facilia will form at strong nuclear

Peab builds new psychiatric premises in Kalmar

Peab has been commissioned to build new psychiatric premises in Kalmar. The customer is Kalmar County Council and the contract is worth SEK 745 million.The project is a turnkey contract in partnering. During Phase 1 Peab has together with the customer prepared the system documents focusing on patients and patient usefulness in which the building will create an innovative caring environment. Kalmar Municipality has needed to expand its psychiatric facilities for a long time. Construction will start in the beginning of June 2018 and the project is expected be completed in the winter of

There are no items matching the current filter
There are no more items matching the current filter
Back to top